About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01729182

Nexium Capsules LDA Specific Clinical Experience Investigation

The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or d...

Lead sponsor: AstraZeneca•47 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

AstraZeneca

Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with Low dose Aspirin (LDA).

Age

All ages

Sex

ALL

Healthy Volunteers

No

Exclusion Criteria

•Patients having gastric ulcer/duodenal ulcer when Nexium is started (Active phase (A1, A2) or healing phase (H1, H2) of Sakita-Miwa classification on endoscopy).
•Patients who had been given Nexium for suppression of recurrence of gastric ulcer/duodenal ulcer.

Related studies

RECRUITINGPhase 1

Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

NCT07385235 · Gastric Ulcer

Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

NCT06848400 · Gastric Lesion, Gastritis, and more

Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

NCT03972956 · Colorectal Cancer, Gastric Cancer, and more

Active Not RecruitingNA

To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

NCT04702542 · Gastritis Chronic, Gastroduodenitis, and more

COMPLETEDPhase 3

A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

NCT05656092 · Gastric Ulcer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 7, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment2,363

Start dateJan 2013

Last updatedAug 7, 2019

Condition

Gastric Ulcer Duodenal Ulcer

Locations shown

Research Site

Aichi

Research Site

Akita

Research Site

Aomori

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 7, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions